MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine’) is a recreational designer drug with dissociative effects.
It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020, and was made illegal in Hungary in April 2021.
In the US it is listed as: CA: Schedule I; DE: NpSG (Industrial and scientific use only)
Mentioned in the NFLIS Snapshot Report (March 2023)